EU Policy and Regulatory updates - March / April 2023
Bimonthly Policy and Regulatory updates from RPP Group
Bimonthly Policy and Regulatory updates from RPP Group
If we can submit in silico evidence for regulatory approval to the FDA, we still need to rely exclusively on clinical trial result to the rest of the world until regulation are harmonized! Really? Let's ask the question to the regulators.
Dr. Bassil Akra, a visionary leader in European medtech regulation, will reveal how medical device and IVD rules are evolving.
You’re invited… and yes, this party is free.
Fill in the fields you find below